Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT00952367
Eligibility Criteria:
Inclusion Criteria
* Healthy children aged 12-18 months
Exclusion Criteria
* Use of antibiotics up to 15 days prior to study inclusion
* Malformation or injury of the nasopharynx that makes the procedure of taking a nasopharyngeal swab impossible
* Children with chronic infectious (chronic otitis media or chronic sinusitis prior to study inclusion.
* Received any pneumococcal vaccine in the past.
* Children who have already provided a NP sample in the same study period.
* Any relevant hemorrhagic disorder.
* Any febrile process (fever ≥ 38°C) at time of screening.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
18 Months
Study:
NCT00952367
Study Brief:
Protocol Section:
NCT00952367